Cargando…

Optic pathway glioma and the sex association in neurofibromatosis type 1: a single-center study

BACKGROUND: Low-grade optic pathway glioma (OPG) develops in 15–20% of children with neurofibromatosis type 1 (NF1). OPGs are symptomatic in 30–50% and one-third of these require treatment. A few studies have suggested female sex as a risk factor for visual impairment associated with NF1-OPG. This d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Henning, Anne Munk, Handrup, Mette Møller, Kjeldsen, Sia Mariann, Larsen, Dorte Ancher, Ejerskov, Cecilie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607578/ https://www.ncbi.nlm.nih.gov/pubmed/34809690 http://dx.doi.org/10.1186/s13023-021-02121-8

Ejemplares similares

Clinical features and disease severity in patients with mosaic neurofibromatosis type 1: a single-center study and literature review
por: Ejerskov, C., et al.
Publicado: (2021)

Clinical Characteristics and Management of Children and Adults with Neurofibromatosis Type 1 and Plexiform Neurofibromas in Denmark: A Nationwide Study
por: Ejerskov, Cecilie, et al.
Publicado: (2022)

Transition to adult care of young patients with neurofibromatosis type 1 and cognitive deficits: a single-centre study
por: Lausdahl, S., et al.
Publicado: (2022)

Cohort profile: life with neurofibromatosis 1 – the Danish NF1 cohort
por: Doser, Karoline, et al.
Publicado: (2022)

Employment, occupation, and income in adults with neurofibromatosis 1 in Denmark: a population- and register-based cohort study
por: Kenborg, Line, et al.
Publicado: (2023)

Constipation in adults with neurofibromatosis type 1
por: Ejerskov, Cecilie, et al.
Publicado: (2017)

Exploring associations between constipation, severity of neurofibromatosis type 1 and NF1 mutational spectrum
por: Ejerskov, Cecilie, et al.
Publicado: (2021)

MRI Screening for Optic Gliomas in Neurofibromatosis Type 1
por: Millichap, J. Gordon
Publicado: (2015)

Non-optic glioma in adults and children with neurofibromatosis 1
por: Sellmer, Laura, et al.
Publicado: (2017)

School performances in children with cataract: results from a population-based cohort study
por: Al-Bakri, Moug, et al.
Publicado: (2023)

Pacemaker Implantation in Juvenile Neuronal Ceroid Lipofuscinosis (CLN3)–A Long-Term Follow-Up Study
por: Handrup, Mette Møller, et al.
Publicado: (2022)

Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety
por: Hansen, Niklas Cyril, et al.
Publicado: (2023)

Optic Pathway Glioma in Children with Neurofibromatosis Type 1: A Multidisciplinary Entity, Posing Dilemmas in Diagnosis and Management Multidisciplinary Management of Optic Pathway Glioma in Children with Neurofibromatosis Type 1
por: Lohkamp, Laura-Nanna, et al.
Publicado: (2022)

Optic Nerve Glioma in Neurofibromatosis: Radiological Clues to Diagnosis in a Young Child
por: Patel, Harsh, et al.
Publicado: (2021)

Current update on the visual outcome of optic pathway glioma associated with neurofibromatosis type-1
por: Zeid, Janice Lasky
Publicado: (2022)

Neurofibromatosis Type 1-Associated Optic Pathway Gliomas: Current Challenges and Future Prospects
por: Tang, Yunshuo, et al.
Publicado: (2023)

A case of neurofibromatosis 1 presenting with optic pathway glioma with an early onset and an aggressive course
por: Ganesh, Suma, et al.
Publicado: (2008)

An Update on Neurofibromatosis Type 1-Associated Gliomas
por: Lobbous, Mina, et al.
Publicado: (2020)

Serial MRIs provide novel insight into natural history of optic pathway gliomas in patients with neurofibromatosis 1
por: Sellmer, Laura, et al.
Publicado: (2018)

Homonymous Retinal Ganglion Cell Layer Atrophy With Asymptomatic Optic Tract Glioma in Neurofibromatosis Type I
por: Momen, Amirah I., et al.
Publicado: (2020)

Optic Pathway Glioma in Type 1 Neurofibromatosis: Review of Its Pathogenesis, Diagnostic Assessment, and Treatment Recommendations
por: Cassina, Matteo, et al.
Publicado: (2019)

RONC-05. PRESERVING VISION IN OPTIC PATHWAY GLIOMA AMONG PATIENTS WITHOUT NEUROFIBROMATOSIS TYPE 1
por: Hanania, Alexander, et al.
Publicado: (2020)

Neurofibromatosis Masquerading as Disorder of Sex Development
por: Mangaraj, Swayamsidha, et al.
Publicado: (2019)

Optic pathway glioma, scoliosis, Chiari type 1 malformation, and syringomyelia in a patient with neurofibromatosis type 1
por: Incecık, Faruk, et al.
Publicado: (2013)

Rare Case of Optic Pathway Glioma with Extensive Intra-Ocular Involvement in a Child with Neurofibromatosis Type 1
por: Gupta, Vasudha, et al.
Publicado: (2015)

Non-Coding RNA and Tumor Development in Neurofibromatosis Type 1: ANRIL Rs2151280 Is Associated with Optic Glioma Development and a Mild Phenotype in Neurofibromatosis Type 1 Patients
por: Tritto, Viviana, et al.
Publicado: (2019)

Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas
por: Byrne, Susan, et al.
Publicado: (2017)

Co‐occurrence of neurofibromatosis type 1 and optic nerve gliomas with autosomal dominant polycystic kidney disease type 2
por: Peces, Ramón, et al.
Publicado: (2020)

Risk of Optic Pathway Glioma in Neurofibromatosis Type 1: No Evidence of Genotype–Phenotype Correlations in a Large Independent Cohort
por: Melloni, Giulia, et al.
Publicado: (2019)

Neurofibromatosis type 1: a single center's experience in Korea
por: Kim, Min Jeong, et al.
Publicado: (2014)

Neurofibromatosis Type 1 in Children: A Single-Center Experience
por: Gonca Kaçar, Ayşe, et al.
Publicado: (2021)

Rethinking the Management of Optic Pathway Gliomas: A Single Center Experience
por: Del Baldo, Giada, et al.
Publicado: (2022)

Identification of Mutation Regions on NF1 Responsible for High- and Low-Risk Development of Optic Pathway Glioma in Neurofibromatosis Type I
por: Xu, Min, et al.
Publicado: (2018)

Quantitative MRI demonstrates abnormalities of the third ventricle subventricular zone in neurofibromatosis type-1 and sporadic paediatric optic pathway glioma
por: Boonzaier, Natalie R., et al.
Publicado: (2020)

High-Dose Intravenous Vitamin C Treatment of a Child with Neurofibromatosis Type 1 and Optic Pathway Glioma: A Case Report
por: Mikirova, Nina, et al.
Publicado: (2016)

Commentary: Identification of Mutation Regions on NF1 Responsible for High- and Low-Risk Development of Optic Pathway Glioma in Neurofibromatosis Type I
por: Anastasaki, Corina, et al.
Publicado: (2019)

Sex bias in autism spectrum disorder in neurofibromatosis type 1
por: Garg, Shruti, et al.
Publicado: (2016)

Challenges in Drug Discovery for Neurofibromatosis Type 1-Associated Low-Grade Glioma
por: Ricker, Cora A., et al.
Publicado: (2016)

Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1
por: Corsello, Giovanni, et al.
Publicado: (2018)

Neurofibromatosis: an update of ophthalmic characteristics and applications of optical coherence tomography
por: Abdolrahimzadeh, Barmak, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1fl2atc6uon149ku39f4i9b4us